510(k) device
LAA Exclusion System
Syntheon, LLC · Left Atrial Appendage Clip, Implantable (PZX, Class II) · First FDA decision Oct 28, 2022, newest Aug 30, 2023Atrial fibrillationStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
26
Naming "LAA Exclusion"
MAUDE reports
305
Brand "LAA Exclusion", since 2015
PubMed studies
140
Mentioning "LAA Exclusion"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LAA Exclusion System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- LAA Exclusion System510(k)
K232295 · Decided Aug 30, 2023 · 29 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
K220305 · Decided Oct 28, 2022 · 268 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "LAA Exclusion", any status and sponsor, newest update first.
Edwards LifesciencesPublic (EW)
NCT07742839 · 168 participants (planned) · Start Nov 30, 2026 · Primary completion Jul 10, 2027
Device: Edwards ECLIPTIS Left Atrial Appendage Exclusion System · For: Atrial Appendage
- Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction TrialPivotal-lookingActive, not recruiting
AtriCure, Inc.Public (ATRC)
NCT05478304 · 6,573 participants · Start Jan 25, 2023 · Primary completion Dec 2031
Device: AtriClip LAA Exclusion System · For: Ischemic Stroke; Systemic Embolism
Sites: Huntsville, Alabama; Scottsdale, Arizona; Jonesboro, Arkansas · 138 sites in all
- CLIP-IT Post-Market StudyActive, not recruiting
Medtronic Cardiac SurgeryPublic (MDT)
NCT06203054 · 198 participants · Start Feb 26, 2024 · Primary completion Aug 26, 2025
Device: Penditure™ Left Atrial Appendage (LAA) Exclusion System · For: Left Atrial Appendage Exclusion
Sites: Atlanta, Georgia; Chicago, Illinois; Carmel, Indiana · 15 sites in all
23 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LAA Exclusion", and for the whole product code for context.
This brand
305 reports: 170 malfunction, 121 injury, 14 death
Whole product code PZX
145 reports: 50 malfunction, 87 injury, 7 death
Newest reports for this brand
1219930-2026-06246 · Received Oct 9, 2026 · Event dated Sep 1, 2026
Device type: Left Atrial Appendage Clip, Implantable (PZX)
Device problem as coded: Mechanical Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding; Unspecified Tissue Injury
- Penditure LAA Exclusion SystemMalfunction
1219930-2026-06173 · Received Oct 6, 2026 · Event dated Sep 24, 2026
Device type: Left Atrial Appendage Clip, Implantable (PZX)
Device problem as coded: Mechanical Problem; Material Separation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3011706110-2026-00038 · Received Oct 4, 2026 · Event dated Sep 9, 2026
Device type: Suture, Nonabsorbable, Synthetic, Polyethylene (GAT)
Device problem as coded: Entrapment of Device
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "LAA Exclusion"[tiab]. The summary above synthesizes these.
- LARIAT Trial Updates.
Musat D, Mittal S · J Atr Fibrillation · 2018Review
- Cardiovascular Therapies Targeting Left Atrial Appendage.
Turagam MK, Velagapudi P, Kar S, et al. · J Am Coll Cardiol · 2018Review
- The Cost Effectiveness of LAA Exclusion.
Kreidieh B, Mañero MR, Cortez SH, et al. · J Atr Fibrillation · 2016Review
- Left Atrial Appendage Occlusion for Stroke Prevention.
Chanda A, Reilly JP · Prog Cardiovasc Dis · 2017Review
- Clinical Implications and Management Strategies for Left Atrial Appendage Leaks.
Sahore A, Della Rocca DG, Anannab A, et al. · Card Electrophysiol Clin · 2020Review
- Understanding the role of the left atrial appendage on the flow in the atrium.
Bshennaty A, Vogl BJ, Bavo AM, et al. · Catheter Cardiovasc Interv · 2024Research Support, Non-U.S. Gov't
- Totally Thoracoscopic Closure of the Left Atrial Appendage.
Ramlawi B, Bedeir K, Edgerton JR · Ann Thorac Surg · 2019
- Left atrial appendage exclusion in atrial fibrillation.
Rozen G, Margolis G, Marai I, et al. · Front Cardiovasc Med · 2022Review
- Left Atrial Appendage Occlusion/Exclusion: Procedural Image Guidance with Transesophageal Echocardiography.
Vainrib AF, Harb SC, Jaber W, et al. · J Am Soc Echocardiogr · 2018Review
- Left atrial appendage exclusion-Where do we stand?
Sakellaridis T, Argiriou M, Charitos C, et al. · J Thorac Dis · 2014Review
- Percutaneous epicardial approach for LAA ligation.
Sanchez JM, Lee A, Bartus K, et al. · J Interv Card Electrophysiol · 2021
- Left Atrial Occlusion Device Implantation: the Role of the Echocardiographer.
Altszuler D, Vainrib AF, Bamira DG, et al. · Curr Cardiol Rep · 2019Review
Other devices of this type
Also filed under product code PZX.
- AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0)AtriCure, Inc. · 510(k) 2023
- ACHM30 AtriClip FLEX-Mini LAA Exclusion SystemAtriCure, Inc. · 510(k) 2026
- ECLIPTIS Left Atrial Appendage Exclusion System (ECS135)Edwards Lifesciences · 510(k) 2026
- ATLAAS (Atraumatic Left Atrial Appendage System) (AD)Genesee Biomedical, Inc. · 510(k) 2026
- AtriClip PRO-Mini LAA Exclusion System (PROM)AtriCure, Inc. · 510(k) 2025
- AtriClip FLEX-Mini LAA Exclusion System (ACHM)AtriCure, Inc. · 510(k) 2024
- ArtiClip LAA Exclusion SystemAtriCure, Inc. · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.